Viewing Study NCT00317720

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:20 AM
Ignite Modification Date: 2025-12-26 @ 3:21 AM
Study NCT ID: NCT00317720
Status: COMPLETED
Last Update Posted: 2025-04-30
First Post: 2006-04-21
Is NOT Gene Therapy: False
Has Adverse Events: True
Brief Title: Trastuzumab and RAD001 in Patients With Human Epidermal Growth Receptor 2 (HER-2) Overexpressing Breast Cancer
Sponsor: M.D. Anderson Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
None Neoplasm Metastasis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Breast Cancer View
None Metastatic Breast Cancer View
None Trastuzumab View
None RAD001 View
None Herceptin View